primary antibodies cd146 clone ep54 Search Results


90
OriGene cd146
Demographic patient characteristics (n=60).
Cd146, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+cd146+clone+ep54/CD146+(MCAM)+Mouse+Monoclonal+Antibody/pmc07202285-118-26-33
Average 90 stars, based on 1 article reviews
cd146 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Demographic patient characteristics (n=60).

Journal: Oncology Letters

Article Title: Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma

doi: 10.3892/ol.2020.11505

Figure Lengend Snippet: Demographic patient characteristics (n=60).

Article Snippet: Specimens were incubated overnight at 4°C with primary antibodies against the following molecules: Survivin (dilution, 1:100; rabbit monoclonal, clone EP119; OriGene Technologies, Inc.; cat. no. S1130), CD146 (dilution, 1:100; rabbit monoclonal, clone EP54; OriGene Technologies, Inc.; cat. no. GTX34461) and Ki-67 (dilution, 1:200; rabbit monoclonal, clone EP5; OriGene Technologies, Inc.; cat. no. GTX16667).

Techniques:

Representative IHC images of CD146, survivin and Ki-67 expression. Expression of CD146 in epithelioid MPeM: (A) Negative; (B) 1+; (C) 2+; (D) 3+. Expression of CD146 in non-epithelioid MPeM: (E) Negative; (F) 1+; (G) 2+; (H) 3+. Expression of survivin in epithelioid MPeM: (I) Negative; (J) 1+; (K) 2+; (L) 3+. Expression of survivin in non-epithelioid MPeM: (M) Negative; (N) 1+; (O) 2+; (P) 3+. Expression of Ki-67 in epithelioid MPeM: (Q) Lower expression; (R) higher expression. Expression of Ki-67 in non-epithelioid MPeM: (S) Lower expression; (T) higher expression. Staining of CD146 was observed in the cytoplasm and cell membrane, staining of survivin was found in the nucleus and cytoplasm, while Ki-67 staining was nuclear. Magnification, ×400. IHC, immunohistochemistry; MPeM, malignant peritoneal mesothelioma.

Journal: Oncology Letters

Article Title: Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma

doi: 10.3892/ol.2020.11505

Figure Lengend Snippet: Representative IHC images of CD146, survivin and Ki-67 expression. Expression of CD146 in epithelioid MPeM: (A) Negative; (B) 1+; (C) 2+; (D) 3+. Expression of CD146 in non-epithelioid MPeM: (E) Negative; (F) 1+; (G) 2+; (H) 3+. Expression of survivin in epithelioid MPeM: (I) Negative; (J) 1+; (K) 2+; (L) 3+. Expression of survivin in non-epithelioid MPeM: (M) Negative; (N) 1+; (O) 2+; (P) 3+. Expression of Ki-67 in epithelioid MPeM: (Q) Lower expression; (R) higher expression. Expression of Ki-67 in non-epithelioid MPeM: (S) Lower expression; (T) higher expression. Staining of CD146 was observed in the cytoplasm and cell membrane, staining of survivin was found in the nucleus and cytoplasm, while Ki-67 staining was nuclear. Magnification, ×400. IHC, immunohistochemistry; MPeM, malignant peritoneal mesothelioma.

Article Snippet: Specimens were incubated overnight at 4°C with primary antibodies against the following molecules: Survivin (dilution, 1:100; rabbit monoclonal, clone EP119; OriGene Technologies, Inc.; cat. no. S1130), CD146 (dilution, 1:100; rabbit monoclonal, clone EP54; OriGene Technologies, Inc.; cat. no. GTX34461) and Ki-67 (dilution, 1:200; rabbit monoclonal, clone EP5; OriGene Technologies, Inc.; cat. no. GTX16667).

Techniques: Expressing, Staining, Membrane, Immunohistochemistry

Association and differences of survivin and  CD146  expression with clinicopathologic parameters and Ki-67LI in patients with malignant peritoneal mesothelioma.

Journal: Oncology Letters

Article Title: Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma

doi: 10.3892/ol.2020.11505

Figure Lengend Snippet: Association and differences of survivin and CD146 expression with clinicopathologic parameters and Ki-67LI in patients with malignant peritoneal mesothelioma.

Article Snippet: Specimens were incubated overnight at 4°C with primary antibodies against the following molecules: Survivin (dilution, 1:100; rabbit monoclonal, clone EP119; OriGene Technologies, Inc.; cat. no. S1130), CD146 (dilution, 1:100; rabbit monoclonal, clone EP54; OriGene Technologies, Inc.; cat. no. GTX34461) and Ki-67 (dilution, 1:200; rabbit monoclonal, clone EP5; OriGene Technologies, Inc.; cat. no. GTX16667).

Techniques: Expressing

Survivin (A) CD146 (C) and Ki-67 (E) expression is absent in normal mesothelium. Survivin (B) CD146 (D) and Ki-67 (F) expression is absent in peritonitis specimens (B, D, F). Magnification ×400.

Journal: Oncology Letters

Article Title: Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma

doi: 10.3892/ol.2020.11505

Figure Lengend Snippet: Survivin (A) CD146 (C) and Ki-67 (E) expression is absent in normal mesothelium. Survivin (B) CD146 (D) and Ki-67 (F) expression is absent in peritonitis specimens (B, D, F). Magnification ×400.

Article Snippet: Specimens were incubated overnight at 4°C with primary antibodies against the following molecules: Survivin (dilution, 1:100; rabbit monoclonal, clone EP119; OriGene Technologies, Inc.; cat. no. S1130), CD146 (dilution, 1:100; rabbit monoclonal, clone EP54; OriGene Technologies, Inc.; cat. no. GTX34461) and Ki-67 (dilution, 1:200; rabbit monoclonal, clone EP5; OriGene Technologies, Inc.; cat. no. GTX16667).

Techniques: Expressing

Univariate and multivariate analyses of factors affecting OS in patients with malignant peritoneal mesothelioma.

Journal: Oncology Letters

Article Title: Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma

doi: 10.3892/ol.2020.11505

Figure Lengend Snippet: Univariate and multivariate analyses of factors affecting OS in patients with malignant peritoneal mesothelioma.

Article Snippet: Specimens were incubated overnight at 4°C with primary antibodies against the following molecules: Survivin (dilution, 1:100; rabbit monoclonal, clone EP119; OriGene Technologies, Inc.; cat. no. S1130), CD146 (dilution, 1:100; rabbit monoclonal, clone EP54; OriGene Technologies, Inc.; cat. no. GTX34461) and Ki-67 (dilution, 1:200; rabbit monoclonal, clone EP5; OriGene Technologies, Inc.; cat. no. GTX16667).

Techniques:

Kaplan-Meier survival curves for different predictors. (A) Ki-67 grade 2 expression; (B) CD146 grade 4 expression; (C) survivin grade 4 expression; (D) forest plot of disease-free survival hazard ratios of major subgroups (exploratory analysis). Dashed lines represent median survival. PCI, peritoneal cancer index. Treatment protocols 0, best supportive care; Treatment protocols 1, intraperitoneal chemotherapy; Treatment protocols 2, systemic chemotherapy. *P<0.05. ***P<0.001.

Journal: Oncology Letters

Article Title: Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma

doi: 10.3892/ol.2020.11505

Figure Lengend Snippet: Kaplan-Meier survival curves for different predictors. (A) Ki-67 grade 2 expression; (B) CD146 grade 4 expression; (C) survivin grade 4 expression; (D) forest plot of disease-free survival hazard ratios of major subgroups (exploratory analysis). Dashed lines represent median survival. PCI, peritoneal cancer index. Treatment protocols 0, best supportive care; Treatment protocols 1, intraperitoneal chemotherapy; Treatment protocols 2, systemic chemotherapy. *P<0.05. ***P<0.001.

Article Snippet: Specimens were incubated overnight at 4°C with primary antibodies against the following molecules: Survivin (dilution, 1:100; rabbit monoclonal, clone EP119; OriGene Technologies, Inc.; cat. no. S1130), CD146 (dilution, 1:100; rabbit monoclonal, clone EP54; OriGene Technologies, Inc.; cat. no. GTX34461) and Ki-67 (dilution, 1:200; rabbit monoclonal, clone EP5; OriGene Technologies, Inc.; cat. no. GTX16667).

Techniques: Expressing